3.67
price up icon6.69%   0.23
after-market アフターアワーズ: 3.72 0.05 +1.36%
loading
前日終値:
$3.44
開ける:
$3.47
24時間の取引高:
5.17M
Relative Volume:
0.93
時価総額:
$323.90M
収益:
$409.00K
当期純損益:
$-101.35M
株価収益率:
-2.2378
EPS:
-1.64
ネットキャッシュフロー:
$-71.49M
1週間 パフォーマンス:
+1.10%
1か月 パフォーマンス:
-10.05%
6か月 パフォーマンス:
-42.83%
1年 パフォーマンス:
-45.22%
1日の値動き範囲:
Value
$3.4286
$3.70
1週間の範囲:
Value
$3.35
$3.70
52週間の値動き範囲:
Value
$2.90
$11.16

Altimmune Inc Stock (ALT) Company Profile

Name
名前
Altimmune Inc
Name
セクター
Healthcare (1146)
Name
電話
(240) 654-1450
Name
住所
910 CLOPPER ROAD, GAITHERSBURG, MD
Name
職員
59
Name
Twitter
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
ALT's Discussions on Twitter

ALT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ALT
Altimmune Inc
3.67 303.60M 409.00K -101.35M -71.49M -1.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
389.08 99.27B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.96 62.28B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.18 59.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
707.96 43.34B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
300.14 36.72B 3.81B -644.79M -669.77M -6.24

Altimmune Inc Stock (ALT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 再開されました Goldman Sell
2025-02-28 開始されました William Blair Mkt Perform
2025-01-08 開始されました Stifel Buy
2024-11-12 開始されました UBS Buy
2024-04-29 ダウングレード Guggenheim Buy → Neutral
2024-01-24 開始されました Goldman Neutral
2023-03-22 ダウングレード Goldman Buy → Neutral
2022-12-01 開始されました Goldman Buy
2021-12-29 再開されました Jefferies Buy
2021-06-02 開始されました H.C. Wainwright Buy
2021-02-11 開始されました Guggenheim Buy
2020-12-14 開始されました Jefferies Buy
2020-11-12 繰り返されました B. Riley Securities Buy
2020-09-25 開始されました B. Riley FBR Buy
2020-08-14 開始されました Evercore ISI Outperform
2020-07-31 開始されました Piper Sandler Overweight
2020-07-28 開始されました JMP Securities Mkt Outperform
2020-02-24 再開されました ROTH Capital Buy
2019-07-19 開始されました ROTH Capital Buy
2017-10-09 開始されました Piper Jaffray Overweight
すべてを表示

Altimmune Inc (ALT) 最新ニュース

pulisher
Aug 27, 2025

Altimmune Inc. stock prediction for this weekTake Profit & Risk Controlled Stock Pick Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Altimmune: Is There Still Hope For Pemvidutide? I Believe There Is (Upgrade) (NASDAQ:ALT) - Seeking Alpha

Aug 27, 2025
pulisher
Aug 27, 2025

Altimmune (ALT) Stock Rises on FDA's Acceptance of Surrogate Endpoint - GuruFocus

Aug 27, 2025
pulisher
Aug 27, 2025

Will Altimmune Inc. price bounce be sustainableBond Market & Consistent Profit Trade Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Aug 27, 2025
pulisher
Aug 27, 2025

ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Aug 27, 2025
pulisher
Aug 27, 2025

FDA accepts lenient MASH trial requirement (VKTX:NASDAQ) - Seeking Alpha

Aug 27, 2025
pulisher
Aug 27, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - PR Newswire

Aug 27, 2025
pulisher
Aug 26, 2025

Using Python tools to backtest Altimmune Inc. strategiesPortfolio Risk Summary & Growth Focused Entry Point Reports - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Altimmune Inc. stock volume spike explainedTrend Reversal & Accurate Entry/Exit Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Top chart patterns to watch in Altimmune Inc.2025 Momentum Check & Weekly Breakout Watchlists - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Contact The Gross Law Firm by October 6, 2025 Deadline to Join Class Action Against Altimmune, Inc.(ALT) - PR Newswire

Aug 26, 2025
pulisher
Aug 26, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Novo, - GlobeNewswire

Aug 26, 2025
pulisher
Aug 26, 2025

Altimmune to Participate in Upcoming Investor Conferences - The Manila Times

Aug 26, 2025
pulisher
Aug 26, 2025

Late-Stage Biotech Altimmune Announces Triple Conference Presence: Wells Fargo, HC Wainwright, Morgan Stanley - Stock Titan

Aug 26, 2025
pulisher
Aug 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming DeadlinesALT - WV News

Aug 25, 2025
pulisher
Aug 25, 2025

Levi & Korsinsky Moves to SueWallSt for Altimmune, Inc. Investors That Lost Money - Stockhouse

Aug 25, 2025
pulisher
Aug 24, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. - GlobeNewswire

Aug 24, 2025
pulisher
Aug 24, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Aug 24, 2025
pulisher
Aug 24, 2025

Is Altimmune Inc. still worth holding after the dip2025 Growth vs Value & Low Risk Profit Maximizing Plans - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

Real time breakdown of Altimmune Inc. stock performanceJuly 2025 Recap & Free Technical Pattern Based Buy Signals - Newser

Aug 24, 2025
pulisher
Aug 22, 2025

Class Action Filed Against Altimmune, Inc. (ALT)October 6, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire

Aug 22, 2025
pulisher
Aug 21, 2025

Altimmune, Inc. Sued for Securities Law Violations - GlobeNewswire

Aug 21, 2025
pulisher
Aug 21, 2025

Faruqi & Faruqi investigates potential claims against Altimmune, Inc. - AInvest

Aug 21, 2025
pulisher
Aug 20, 2025

ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc. - PR Newswire

Aug 20, 2025
pulisher
Aug 20, 2025

Will Altimmune Inc. continue its uptrend2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Altimmune, Inc. (NASDAQ:ALT) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

Aug 20, 2025
pulisher
Aug 19, 2025

Altimmune wins FDA fast track status for alcohol use disorder therapy - MSN

Aug 19, 2025
pulisher
Aug 19, 2025

Will Altimmune Inc. stock recover after recent dropQuarterly Market Summary & Precise Trade Entry Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Altimmune Inc (ALT) Stock: A Comprehensive 52-Week Review - investchronicle.com

Aug 19, 2025
pulisher
Aug 19, 2025

ALT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Altimmune, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Aug 19, 2025
pulisher
Aug 19, 2025

Altimmune (ALT) Gains FDA Fast Track for Alcohol Use Disorder Treatment - GuruFocus

Aug 19, 2025
pulisher
Aug 19, 2025

Shareholders that lost money on Altimmune, Inc.(ALT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - MarketScreener

Aug 19, 2025
pulisher
Aug 19, 2025

Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD) - The Manila Times

Aug 19, 2025
pulisher
Aug 19, 2025

Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD) | ALT Stock News - GuruFocus

Aug 19, 2025
pulisher
Aug 19, 2025

Altimmune's Pemvidutide Receives FDA Fast Track Designation for Alcohol Use Disorder Treatment - Quiver Quantitative

Aug 19, 2025
pulisher
Aug 19, 2025

Trend analysis for Altimmune Inc. this weekMarket Activity Recap & Scalable Portfolio Growth Ideas - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Lost Money on Altimmune, Inc. (ALT)? Join Class Action Before October 6, 2025Contact Levi & Korsinsky - ACCESS Newswire

Aug 18, 2025
pulisher
Aug 18, 2025

Class Action Filed Against Altimmune, Inc. – Investors with Losses Encouraged to Contact Johnson Fistel - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

Rosen Law Firm Urges Altimmune, Inc. (NASDAQ: ALT) Stockholders to Contact the Firm for Information About Their Rights - PR Newswire

Aug 18, 2025
pulisher
Aug 18, 2025

ALT LAWSUIT ALERT: The Gross Law Firm Notifies Altimmune, - GlobeNewswire

Aug 18, 2025

Altimmune Inc (ALT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
大文字化:     |  ボリューム (24 時間):